CIONC-Centro Integrado de Oncologia de Curitiba

Paraana 80810050

0 studies enrolling now · 1 studies all time

What they study most

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer

Studies at this site

• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling